+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Microfluidics Market: Focus on Application, Type, End User, Country Data (15 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029

  • ID: 4895469
  • Report
  • December 2019
  • Region: Global
  • 190 Pages
  • BIS Research
1 of 6

Enquire about COVID-19 updates for this product.

Enquire Now
Global Microfluidics Market to Grow at a CAGR of 13.73% from 2019-2029

FEATURED COMPANIES

  • 1CellBio, Inc.
  • Cellix Ltd.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Mission Bio
  • MORE

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global microfluidics market?
  • What are the factors resulting in the emerging trends within the global microfluidics market?
  • How is each segment of the global microfluidics market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
  • What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
  • What are the key applications in the global microfluidics market? What are the major segments of these applications?
  • Who are the key manufacturers the global microfluidics products, and what are their contributions?

The global microfluidics industry analysis projects the market to grow at a significant CAGR of 13.73% during the forecast period, 2019-2029. The microfluidics market generated $10,260.6 million in revenue in 2018, in terms of value.

The microfluidics market growth has been primarily attributed to the major drivers in this market such as growing demand for non-invasive and rapid diagnostics, an increase in the adoption of personalized medicines on a global level, significant external funding for executing research and development exercises and growing demand for point-of-care testing. The challenges include lack of standardization, a lack of high-complexity testing centers, and high capital requirement hampering the global reach.

Expert Quote

“We strongly believe such technology will help to fill the gaps in existing immunoassay technology and be applied directly to biological samples such as blood, saliva, or urine.”

Scope of the Market Intelligence on Microfluidics Market

The microfluidics research provides a holistic view of the market in terms of various factors influencing it, including strategic developments and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with industrial and biological research. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global microfluidics market.

Market Segmentation

  • The microfluidics market segmentation (on the basis of application) is segmented point-of-care testing, cell analysis, drug development, and discovery, organ-on-ac-chip, agro-food industry, microbiological research, and other applications.
  • The microfluidics market segmentation (on the basis of type) is segmented into microfluidic chips and microfluidic platforms
  • The microfluidics market segmentation (on the basis of end-user) is segmented into research and academia, biopharmaceutical and biotech companies, diagnostic centers, and other end-users
  • The microfluidics market segmentation (on the basis of geography) is segmented into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

Key Companies in the Microfluidics Market

The key manufacturers who have been contributing significantly to the microfluidics market include 1CellBio Inc., Agilent Technologies Inc., Becton, Dickinson and Company, Cellix Ltd., Micronit Microtechnologies, Fluidigm Corporation, Perkin Elmer Inc., microfluidic Chipshop GmbH, Mission Bio, Merck KgaA, Sphere Fluidics, Thermo Fisher Scientific, Inc., Takara Bio Inc., Qiagen N.V. and uFluidix., among others.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 1CellBio, Inc.
  • Cellix Ltd.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Mission Bio
  • MORE

Executive Summary

1 Research Scope and Methodology
1.1 Scope of the Study
1.2 Research Methodology
1.3 Data Sources
1.4 Assumptions and Limitations
1.5 Data and Prediction Modeling

2 Market Overview
2.1 Characteristics of Market Available Microfluidics Solutions
2.2 Microfluidics in Clinical Diagnostics
2.3 Global Footprint

3 Market Dynamics
3.1 Overview
3.2 Impact Analysis
3.3 Market Drivers
3.3.1 Growing Demand for Non-Invasive and Rapid Diagnosis
3.3.2 Increase in Adoption of Personalized Medicine Shifting the Paradigm from Reaction to Prevention on a Global Level
3.3.3 Significant External Funding for Executing Research and Development Exercises
3.3.4 Growing Demand for Point-of-Care Diagnostics
3.4 Market Restraints
3.4.1 Lack of Standardization
3.4.2 Lack of High Complexity Testing Centers
3.4.3 High Capital Requirement Hampering the Expansion of Global Reach
3.5 Market Opportunities
3.5.1 Massive Scope for Adoption of Microfluidics-based Solutions in Emerging Nations
3.5.2 Increased Use of Microfluidics in Widespread Applications
3.5.3 Hybridization of Technologies

4 Competitive Landscape
4.1 Key Strategies and Developments
4.1.1 Synergistic Activities
4.1.2 Funding and Expansion
4.1.3 Product Launches and Upgrades
4.1.4 Mergers and Acquisitions

5 Global Microfluidics Market (by Product Type)
5.1 Overview
5.2 Microfluidic Platforms
5.3 Microfluidic Chips

6 Global Microfluidics Market (by Application)
6.1 Overview
6.2 Point-of-Care Testing
6.3 Cell Analysis
6.4 Drug Development and Discovery
6.5 Organ-on-a-chip
6.6 Agro-Food Industry
6.7 Microbiological Research
6.8 Other

7 Global Microfluidics Market (by End User) 2018-2029
7.1 Overview
7.2 Research and Academic Laboratories
7.3 Biopharmaceutical and Biotech Companies
7.4 Diagnostic Centers
7.5 Other End Users

8 Global Microfluidics Market (by Region)
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest-of-Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Singapore
8.4.6 Rest-of-APAC
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest-of-Latin America
8.6 Rest-of-the-World

9 Industry Insights
9.1 Market Share Analysis
9.2 Growth Share Analysis

10 Company Profiles
10.1 Overview
10.2 1CellBio, Inc.
10.2.1 Company Overview
10.2.2 Role of 1CellBio, Inc. in the Global Microfluidics Market
10.2.3 SWOT Analysis
10.3 Agilent Technologies, Inc.
10.3.1 Company Overview
10.3.2 Role of Agilent Technologies, Inc. in the Global Microfluidics Market
10.3.3 Financials
10.3.4 Key Insights About Financial Health of the Company
10.3.5 SWOT Analysis
10.4 Becton, Dickinson and Company
10.4.1 Company Overview
10.4.2 Role of Becton, Dickinson and Company in the Global Microfluidics Market
10.4.3 Financials
10.4.4 Key Insights About Financial Health of the Company
10.4.5 SWOT Analysis
10.5 Cellix Ltd.
10.5.1 Company Overview
10.5.2 Role of Cellix Ltd. in the Global Microfluidics Market
10.5.3 SWOT Analysis
10.6 Fluidigm Corporation
10.6.1 Company Overview
10.6.2 Role of Fluidigm Corporation in the Global Microfluidics Market
10.6.3 Financials
10.6.4 Key Insights About Financial Health of the Company
10.6.5 SWOT Analysis
10.7 Micronit MicroTechnologies
10.7.1 Company Overview
10.7.2 Role of Micronit MicroTechnologies in the Global Microfluidics Market
10.7.3 SWOT Analysis
10.8 Illumina, Inc.
10.8.1 Company Overview
10.8.2 Role of Illumina, Inc. in the Global Microfluidics Market
10.8.3 Financials
10.8.4 Key Insights About Financial Health of the Company
10.8.5 SWOT Analysis
10.9 Merck KGaA
10.9.1 Company Overview
10.9.2 Role of Merck KGaA in the Global Microfluidics Market
10.9.3 Financials
10.9.4 Key Insights About Financial Health of the Company
10.9.5 SWOT Analysis
10.10   microfluidic ChipShop GmbH
10.10.1 Company Overview
10.10.2 Role of microfluidic ChipShop GmbH in the Global Microfluidics Market
10.10.3 SWOT Analysis
10.11   Mission Bio
10.11.1 Company Overview
10.11.2 Role of Mission Bio in the Global Microfluidics Market
10.11.3 SWOT Analysis
10.12   PerkinElemer, Inc.
10.12.1 Company Overview
10.12.2 Role of PerkinElemer, Inc.in the Global Microfluidics Market
10.12.3 Financials
10.12.4 Key Insights About Financial Health of the Company
10.12.5 SWOT Analysis
10.13   Sphere Fluidics Limited
10.13.1 Company Overview
10.13.2 Role of Sphere Fluidics Limited in the Global Microfluidics Market
10.13.3 SWOT Analysis
10.14   Thermo Fisher Scientific Inc.
10.14.1 Company Overview
10.14.2 Role of Thermo Fisher Scientific in the Global Microfluidics Market
10.14.3 Financials
10.14.4 Key Insights About Financial Health of the Company
10.14.5 SWOT Analysis
10.15   Takara Bio Inc.
10.15.1 Company Overview
10.15.2 Role of Takara Bio Inc. in the Global Microfluidics Market
10.15.3 Financials
10.15.4 Key Insights About Financial Health of the Company
10.15.5 SWOT Analysis
10.16   QIAGEN N.V.
10.16.1 Company Overview
10.16.2 Role of QIAGEN N.V. in the Global Microfluidics Market
10.16.3 Financials
10.16.4 Key Insights About Financial Health of the Company
10.16.5 SWOT Analysis
10.17   uFluidix
10.17.1 Company Overview
10.17.2 Role of uFluidix in the Global Microfluidics Market
10.17.3 SWOT Analysis

List of Tables
Table 2.1: Market Available Microfluidics Products
Table 3.1: Impact Analysis of Market Drivers
Table 3.2: Impact Analysis of Market Restraints

List of Figures
Figure 1: Impact of Market Drivers and Market Restraints on the Global  Microfluidics Market
Figure 2: Global Microfluidics Market Snapshot, 2018 and 2029
Figure 3: Dominating Segments of the Global Microfluidics Market, 2018 and 2029
Figure 4: Key Strategies Incorporated by Stakeholders of Microfluidics Market to Sustain the Competition (from 2016 to 2019)
Figure 5: Global Microfluidics Market (by Product), 2018 and 2029
Figure 6: Global Microfluidics Market (by End User), 2018 and 2029
Figure 7: Global Microfluidics Market (by Region) 2018 and 2029
Figure 1.1: Global Microfluidics Market Segmentation
Figure 1.2: Global Microfluidics Market Research Methodology
Figure 1.3: Primary Research
Figure 1.4: Secondary Research
Figure 1.5: Data Triangulation
Figure 1.6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 1.7: Top-Down Approach (Segment-Wise Analysis)
Figure 1.8: Assumptions and Limitations
Figure 1.9: Considered Factors for Data Prediction and Modeling
Figure 2.1: Characteristics of Commercially Available Microfluidics Products
Figure 2.2: Global Microfluidics Market, 2018-2029 ($Million)
Figure 4.1: Share of Key Developments and Strategies, 2016–2019
Figure 4.2: Synergistic Activities Share (by Company), 2016 – 2019
Figure 4.3: Funding and Expansion Share (by Company), 2016 –2019
Figure 4.4: Product Launches and Upgrades Share (by Company), 2016–2019
Figure 4.5: Mergers and Acquisitions Share (by Company), 2016–2019
Figure 5.1: Global Microfluidics Market (by Product Type)
Figure 5.2: Global Microfluidics (by Product Type), 2018 and 2029
Figure 5.3: Global Microfluidic Platforms Market, 2018-2029 ($Million)
Figure 5.4: Global Microfluidic Chips Market, 2018-2029 ($Million)
Figure 6.1: Global Microfluidics Market (by Application), 2018-2029 ($Million)
Figure 6.2: Global Microfluidics Market (Point-of-Care Testing), 2018-2029 ($Million)
Figure 6.3: Global Microfluidics Market (By Cell Analysis), 2018-2029 ($Million)
Figure 6.4: Global Microfluidics Market (By Drug Development and Discovery), 2018-2029 ($Million)
Figure 6.5: Global Microfluidics Market (By Organ-on-a-chip), 2018-2029 ($Million)
Figure 6.6: Global Microfluidics Market (By Agro-food Industry), 2018-2029 ($Million)
Figure 6.7: Global Microfluidics Market (By Microbiological Industry), 2018-2029 ($Million)
Figure 6.8: Global Microfluidics Market (by Other Applications), 2018-2029 ($Million)
Figure 7.1: Global Microfluidics Market (by End User)
Figure 7.2: Global Microfluidics Market (by End User), 2018-2029 ($Million)
Figure 7.3: Global Microfluidics Market (by Biopharmaceutical and Biotech companies), 2018-2029 ($Million)
Figure 7.4: Global Microfluidics Market (Diagnostic Centres), 2018-2029 ($Million)
Figure 7.5: Global Microfluidics Market (by Other End-User), 2018-2029 ($Million)
Figure 8.1: Global Microfluidics Market (by Region), 2018 and 2029 ($Million)
Figure 8.2: Global Microfluidics Market (by Region), 2018-2029 ($Million)
Figure 8.3: Global Microfluidics Market Share (by Region), 2018 ($Million)
Figure 8.4: Global Microfluidics Market Share (by Region), 2029 ($Million)
Figure 8.5: North America Microfluidics Market, 2018-2029 ($Million)
Figure 8.6: North America Microfluidics Market (by Country), 2018-2029 ($Million)
Figure 8.7: North America: Market Dynamics
Figure 8.8: The U.S. Microfluidics Market, 2018-2029 ($Million)
Figure 8.9: Canada Microfluidics Market, 2018-2029 ($Million)
Figure 8.10: Europe Microfluidics Market, 2018-2029 ($Million)
Figure 8.11: Europe: Market Dynamics
Figure 8.12: Europe Microfluidics Market (by Country), 2018-2029 ($Million)
Figure 8.13: Germany Microfluidics Market, 2018-2029 ($Million)
Figure 8.14: U.K. Microfluidics Market, 2018-2029 ($Million)
Figure 8.15: France Microfluidics Market, 2018-2029 ($Million)
Figure 8.16: Italy Microfluidics Market, 2018-2029 ($Million)
Figure 8 17: Spain Microfluidics Market, 2018-2029 ($Million)
Figure 8.18: Rest-of-Europe Microfluidics Market, 2018-2029 ($Million)
Figure 8.19: Asia-Pacific Microfluidics Market, 2018-2029 ($Million)
Figure 8.20: APAC: Market Dynamics
Figure 8.21: APAC Global Microfluidics Market (by Country), 2018-2029 ($Million)
Figure 8.22: China Microfluidics Market, 2018-2029 ($Million)
Figure 8.23: Japan Microfluidics Market, 2018-2029 ($Million)
Figure 8.24: India Microfluidics Market, 2018-2029 ($Million)
Figure 8.25: Australia Microfluidics Market, 2018-2029 ($Million)
Figure 8.26: Singapore Microfluidics Market, 2018-2029 ($Million)
Figure 8.27: RoAPAC Microfluidics Market, 2018-2029 ($Million)
Figure 8.28: Latin America Microfluidics Market, 2018-2029 ($Million)
Figure 8.29: Latin America: Market Dynamics
Figure 8.30: Latin America Microfluidics Market (by Country), 2018-2029 ($Million)
Figure 8.31: Brazil Microfluidics Market, 2018-2029 ($Million)
Figure 8.32: Mexico Microfluidics Market, 2018-2029 ($Million)
Figure 8.33: Rest-of-Latin America Microfluidics Market, 2018-2029 ($Million)
Figure 8.34: RoW Microfluidics Market, 2018-2029 ($Million)
Figure 9.1: Market Share Analysis for the Global Microfluidics Market, 2018
Figure 9.2: Growth Share Matrix for Microfluidics Market (by Company), 2018
Figure 10.1: Total Number of Companies Profiled
Figure 10.2: 1CellBio, Inc.: Overall Product Portfolio
Figure 10.3: 1CellBio, Inc.: SWOT Analysis
Figure 10.4: Agilent Technologies, Inc.: Overall Product Portfolio
Figure 10.5: Agilent Technologies, Inc.: Overall Financials, 2016-2018
Figure 10.6: Agilent Technologies, Inc.: Revenue (by Segment), 2016-2018
Figure 10.7: Agilent Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 10.8: Agilent Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 10.9: Agilent Technologies, Inc.: SWOT Analysis
Figure 10.10: Beckton, Dickinson and Company: Overall Product Portfolio
Figure 10.11: Becton, Dickinson and Company: Overall Financials, 2016-2018
Figure 10.12: Becton, Dickinson and Company: Revenue (by Business Segment), 2016-2018
Figure 10.13: Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2016-2018
Figure 10.14: Becton, Dickinson and Company: Revenue (by Region), 2016-2018
Figure 10.15: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
Figure 10.16: Becton, Dickinson and Company: SWOT Analysis
Figure 10.17: Cellix Ltd.: Overall Product Portfolio
Figure 10.18: Cellix Ltd.: SWOT Analysis
Figure 10.19: Fluidigm Corporation: Overall Product Portfolio
Figure 10.20: Fluidigm Corporation: Overall Financials, 2016-2018
Figure 10.21: Fluidigm Corporation: Revenue (by Segment), 2016-2018
Figure 10.22: Fluidigm Corporation: Revenue (by Region), 2016-2018
Figure 10.23: Fluidigm Corporation: R&D Expenditure, 2016-2018
Figure 10.24: Fluidigm Corporation: SWOT Analysis
Figure 10.25: Micronit Micro Technologies: Overall Product Portfolio
Figure 10.26: Micronit Micro Technologies: SWOT Analysis
Figure 10.27: Illumina, Inc.: Overall Product Portfolio
Figure 10.28: Illumina, Inc.: Overall Financials, 2016-2018
Figure 10.29: Illumina, Inc.: Revenue (by Segment), 2016-2018
Figure 10.30: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 10.31: Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 10.32: Illumina, Inc.: SWOT Analysis
Figure 10.33: Merck KGaA: Overall Product Portfolio
Figure 10.34: Merck KGaA: Overall Financials, 2016-2018
Figure 10.35: Merck KGaA: Revenue (by Segment), 2016-2018
Figure 10.36: Merck KGaA: Revenue (by Region), 2016-2018
Figure 10.37: Merck KGaA: R&D Expenditure, 2016-2018
Figure 10.38: Merck KGaA: SWOT Analysis
Figure 10.39: microfluidic ChipShop GmbH: Overall Product Portfolio
Figure 10.40: microfluidic ChipShop GmbH: SWOT Analysis
Figure 10.41: Mission Bio: Overall Product Portfolio
Figure 10.42: Mission Bio: SWOT Analysis
Figure 10.43: PerkinElmer, Inc.: Overall Product Portfolio
Figure 10.44: PerkinElmer, Inc.: Overall Financials, 2016-2018
Figure 10.45: PerkinElmer, Inc.: Sales (by Segment), 2016-2018
Figure 10.46: PerkinElmer, Inc.: Sales (by Region), 2016-2018
Figure 10.47: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
Figure 10.48: PerkinElmer, Inc.: SWOT Analysis
Figure 10.49: Sphere Fluidics Limited: Overall Product Portfolio
Figure 10.50: Sphere Fluidics Limited: SWOT Analysis
Figure 10.51: Thermo Fisher Scientific Inc.: Overall Product Portfolio
Figure 10.52: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 10.53: Thermo Fisher Scientific Inc: Sales (by Segment), 2016-2018
Figure 10.54: Thermo Fisher Scientific Inc.: Sales (by Region), 2016-2018
Figure 10.55: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 10.56: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 10.57: Takara Bio Inc.: Overall Product Portfolio
Figure 10.58: Takara Bio Inc.: Overall Financials, 2016-2018
Figure 10.59: Takara Bio Inc.: Revenue (by Segment), 2016-2018
Figure 10.60: Takara Bio Inc.: Revenue (by Region), 2016-2018
Figure 10.61: Takara Bio Inc.: R&D Expenditure, 2016-2018
Figure 10.62: Takara Bio Inc.: SWOT Analysis
Figure 10.63: QIAGEN N.V.: Overall Product Portfolio
Figure 10.64: QIAGEN N.V.: Overall Financials, 2016-2018
Figure 10.65: QIAGEN N.V.: Revenue (by Segment), 2016-2018
Figure 10.66: QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 10.67: QIAGEN N.V.: R&D Expenditure, 2016-2018
Figure 10.68: QIAGEN N.V.: SWOT Analysis
Figure 10.69: uFluidix: Overall Product Portfolio
Figure 10.70: uFluidix: SWOT Analysis

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 1CellBio, Inc.
  • Cellix Ltd.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Mission Bio
  • MORE

Microfluidic combines the principle of hydrodynamics, electro kinetics, and thermo-capillarity for the development of the system for a wide range of applications. A microfluidic platform comprises several components such as glass or silicon chip, microneedles, microfluidics pumps, and microvalves. For the construction of successful microfluidic platforms, precise mixing of fluids and standardization of the technical components are very significant. In addition to this, microfluidic devices enable enhanced analytical performance, improved biocompatibility, and reduced fabrication cost.

Microfluidics is significantly empowered by the rapid and continual advancements in technology. Owing to the explosion of molecular diagnostics and its applications, all areas of medicine have been significantly affected, with emphasis on point-of-care diagnostics. PCR has gradually evolved from gel analysis to real-time PCR to droplet microfluidics-based digital PCR in more recent times, depicting the increase in the evolutionary demands of the aligned industries.

Additionally, with key players in the market attempting to tackle several emerging diseases, technologies and consequently platforms, have become more refined. The rapid influx of technology within the industry has significantly propelled the entire microfluidics industry into becoming one of the most lucrative industries within the global healthcare market and more precisely, the global precision medicine market.

According to this market intelligence report titled "Global Microfluidics Market – Analysis and Forecast, 2019-2029", the global microfluidics market is expected to grow at a double-digit compound annual growth rate (CAGR) of 13.73% during the forecast period from 2019 to 2029, aided primarily by the impressive growth in the underlying manufacturing market.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global microfluidics market?
  • What are the factors resulting in the emerging trends within the global microfluidics market?
  • How is each segment of the global microfluidics market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
  • What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
  • What are the key applications in the global microfluidics market? What are the major segments of these applications?
  • Who are the key manufacturers the global microfluidics products, and what are their contributions?
Note: Product cover images may vary from those shown
5 of 6
  • 1CellBio, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson, and Company
  • Cellix Ltd.
  • Fluidigm Corporation
  • Micronit MicroTechnologies
  • Illumina, Inc.
  • Merck KGaA
  • microfluidic ChipShop GmbH
  • Mission Bio
  • PerkinElemer, Inc.
  • Sphere Fluidics Limited
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc.
  • QIAGEN N.V.
  • uFluidix
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll